Pomgulated methionil (LY2140023) in schizophrenia patients: a systematic review and meta-analysis
Abstract Background Pomaglumetad methionil (LY2140023 monohydrate) is a potent and selective agonist for metabotropic glutamate receptors (mGluR2/3). Unlike traditional antipsychotics, it does not directly interact with dopamine or serotonin (5-HT2A) receptors, potentially offering a novel mechanism...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-08-01
|
| Edice: | BMC Psychiatry |
| On-line přístup: | https://doi.org/10.1186/s12888-025-07199-z |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
